Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06710795 · ClinicalTrials.gov registry record · NA

AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair

A NA study of Ventral Hernia, sponsored by Medtronic - MITG.

Recruiting
Registry status
NA
Development phase
110
Enrollment target
3
Study locations

NCT06710795 is a NA study of Ventral Hernia that is actively recruiting participants, run by Medtronic - MITG. The registered enrollment target is 110 participants, below the 137-participant average among 18 other Ventral Hernia trials with a reported enrollment target (20% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06710795, a NA study of Ventral Hernia, is actively recruiting participants, sponsored by Medtronic - MITG.

RECRUITING
Registry status
NA
Development phase
110 participants
Enrollment target
3
Study locations

Study Summary

Medtronic is sponsoring and funding the AFFIX study, a prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study. The purpose of this study is to evaluate the performance and safety of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic material to soft tissue in minimally invasive ventral hernia repair procedures.

Conditions Studied

Interventions

  • DEVICE MaxTack™ Motorized Fixation Device

Study Locations (3)

Ohio

  • Cleveland Clinic - Ohio - Cleveland
  • The Ohio State University - Columbus

Florida

  • Cleveland Clinic - Weston Hospital - Weston

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2024-11-26
Est. Completion 2027-02-15
Phase NA

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT06710795

The ClinicalTrials.gov registry entry for NCT06710795 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 137-participant average among 18 other Ventral Hernia trials with a reported enrollment target (20% lower). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which MaxTack™ Motorized Fixation Device is the first listed.

NCT06710795 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Florida.

Frequently Asked Questions

What is clinical trial NCT06710795 about?

NCT06710795 is a clinical study titled "AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair". Medtronic is sponsoring and funding the AFFIX study, a prospective, post-market, multicenter, nonrandomized, single-arm, interventional clinical study. The purpose of this study is to evaluate the performance and safety of the MaxTack™ Motorized Fixation Device when used for fixation of prosthetic m...

What is the current status of trial NCT06710795?

This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2024-11-26. Estimated completion is 2027-02-15.

What conditions does trial NCT06710795 study?

This clinical trial studies the following conditions: Ventral Hernia.

What interventions are being tested in trial NCT06710795?

The interventions under investigation include: MaxTack™ Motorized Fixation Device (DEVICE).

Who is sponsoring clinical trial NCT06710795?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06710795 being conducted?

This trial has 3 study locations across Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventral Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.